4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-209307
Chief Scientific Officer sold 8,000 shares at an average $14.62 ($116,996)
- Chief Scientific Officer acquired 4,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Michaelson Jennifer · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,000 | $4.30 | $17,200 | 174,844 | D |
| 2026-05-05 | Sale : show line 2 in the form 10b5-1 | −7,800 | $14.60 | $113,880 | 167,044 | D |
| 2026-05-05 | Sale : show line 3 in the form 10b5-1 | −200 | $15.58 | $3,116 | 166,844 | D |
| Open-market sales · 8,000 sh · avg $14.62 · $116,996 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-05 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −4,000 | 116,987 | D |
Loading xslF345X06/ownership.xml…